X-ZELL
Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
Founded in 2014-12-01
Singapore, Central Region, Singapore
For Profit
About X-ZELL
X-ZELL is an award-winning medical technology company specializing in the detection and digitization of atypical cells from body liquids such as blood and pleural fluid. Atypical cells are the universal language of cancer diagnostics and commonly found in tissue or fluid samples that were surgically collected from the suspected site. By enabling cytology centres worldwide to detect atypical cells in non-invasive sample material and process them digitally at a new level of detail, we make highly accurate, non-invasive diagnostics accessible at scale.
Company Metrics
- Employees: 11-50
- Monthly Visits: 71
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 5560000 USD
- Last Funding: 4000000 USD (Seed)
- Funding Status: Seed
Technology Stack
X-ZELL actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
Headquarters: Singapore, Central Region, Singapore